Thinking Outside the (Hospital) Box to Reduce 30-Day Post-Discharge Mortality: a Cardiovascular Service Line Example

By Holli White, MPS, Director of Health System Partnerships, HDAI  

Background

* Rose Taylor, an 81-year-old female patient, suffered from an Acute Myocardial Infarction (AMI) and was hospitalized for seven days. Upon release, she had no follow-up primary care or cardiology appointment scheduled and passed away 14 days after her hospital discharge. Could her death have been prevented? Perhaps.

Within the realm of cardiac care, the 30-day all-cause mortality rate is a pivotal measure, offering crucial insights into patient outcomes and enabling healthcare institutions to benchmark their performance against national standards. Hospitals who have a culture of continuous improvement are hyper-focused on inpatient mortality but reducing post-discharge mortality requires a different mindset that stretches outside the hospital walls.

Rose’s story is an example of patients whose post-discharge mortality may have been preventable. Even leading healthcare systems with historically low inpatient mortality rates can take steps to address suboptimal 30-day mortality rates post-discharge.

Different approaches must be taken to identify high-risk patients, enabling clinicians to efficiently and effectively leverage existing care pathways and strategies that are aimed at reducing early mortality risks and elevating patient care standards. 

Risk Predictions to Enhance Patient Management

Accurate, real-time, enterprise-wide risk prediction models that are embedded in the medical record can inform patient triage and treatment decisions, reduce randomness, and improve targeting of patients in the top quintile of mortality risk. While these risk prediction models do not dictate specific interventions, they play a crucial role by flagging patients who require heightened attention during admission, discharge, and follow-up, enabling timely, targeted interventions that can lower post-discharge mortality rates.

A graphic showing how HealthVision can help clinicians

Models and Methodology

Health Data Analytics Institute (HDAI) has developed over 400 predictive models that can be used for patients who are admitted, recently discharged, or in the community (not admitted or recently discharged). The models rely on demographic data (age, sex), diagnoses codes (ICD-10), and event codes (CPT) to calculate likelihood of the defined outcome. Here the specific focus is predicting and identifying patients like Rose, who are at higher risk for 30-day all-cause mortality or readmission.

HDAI’s model methodology and performance has been featured in peer-reviewed publications over the last decade, with the latest conducted with the Center on Outcomes Research at Cleveland Clinic and published in the Journal of Anesthesiology in December 2022 and February 2023.

HDAI’s EMR-embedded or SaaS platform, HealthVisionTM, serves as the Intelligent Health Management System and displays these predictive models and other crucial information to providers and healthcare leaders. HealthVision is transforming care across health systems and value-based care organizations and is made up of three key components:

 

  • The Intelligent Health Record, showcasing the Patient Spotlight, is an easy to digest health profile and risk prediction tool. The Patient Spotlight helps clinicians make sense of the increasingly unwieldy and unmanageable health data in their EMRs (Electronic Medical Record) in real-time. See the sample Patient Spotlight view.
  • The Intelligent Workflow Solution, which includes smart cohorts and rosters that align scarce clinical, documentation, and administrative resources with the patients who will benefit the most. 
Example of the HealthVision dashboard displaying data for a patient
  • The Intelligent Analytics Solution, matching a population to others outside of an organization with the same baseline risk results to fairly assess performance of providers or post-acute networks. These precise comparisons are unlike traditional benchmarks in that they take into consideration illness burden at the patient level and suggest actions that can improve outcomes for each risk group.

The 30-Day Mortality Risk Score Model for Cardiac Patients

To combat 30-day post-discharge mortality rates, HDAI’s 30-day mortality risk score model has been implemented for cardiac patients at leading hospitals. Embedded in existing systems and workflows, this tool merges data-driven insights with clinical expertise.At one health system, the top five cardiac procedures of opportunity include:

  • PTCA with or without stent placement  
  • Insertion; revision; replacement; removal of cardiac pacemaker or cardioverter/defibrillator  
  • Heart valves: repair and replacement (includes TAVI)  
  • Acute myocardial infarction
  • Heart failure and shock   
 

The model identifies the top 20th percentile of patients at risk for all-cause mortality within the next 30 days. By pinpointing such high-risk individuals, clinicians can implement targeted evidence-based interventions, including personalized medication regimens, 7-day follow-ups, and timely specialist consultations to mitigate risks, enhance patient safety, and optimize resource utilization.In retrospect, Rose was identified as high-risk for mortality and readmission within the next 30 days from her discharge. If she had been flagged during her hospital stay and provided with additional services aimed at her specific risk drivers, her outcome post-discharge could have been quite different.

Ensuring Success through Actionability

A critical factor for success is that the data must be actionable for the clinical team. The risk prediction models, such as the 30-day mortality risk score model, aim to identify patients at the highest risk of all-cause mortality within the next 30 days. These high-risk patients can be flagged using the risk scores provided by the model. The risk scores can be displayed in different formats, such as absolute risk, relative risk, percentile risk, or risk summary (categorized as High, Medium, or Low), to support different use cases and clinician preferences.

For example, in AMI patients like Rose, specific risk factors may include previous myocardial infarctions, comorbidities such as diabetes or hypertension, and indicators of cardiac function such as ejection fraction. HealthVision, integrated into the electronic health record system, can then utilize these identified risk factors to provide actionable insights for the clinical team. For example, when a patient with an AMI or HF specific DRG is admitted, updated risk prediction scores can automatically calculate and display the patient’s risk score based on their demographic data, medical history, and new diagnoses pulled from clinical notes and problem lists. This risk score can serve as a prompt for clinicians to assess the patient’s condition more closely and consider appropriate interventions.

Based on the identified risk factors, tailored care pathways can be designed. For Rose and other AMI patients, the first step is to set up a follow-up appointment within 7 days of discharge. Subsequent interventions could include initiation of guideline-directed medical therapy (e.g., aspirin, beta-blockers, ACE inhibitors), referral for cardiac rehabilitation, and education on lifestyle modifications (e.g., smoking cessation, dietary changes).

In conclusion, by leveraging advanced analytics, personalized insights, and real-time guidance, clinicians can make more informed decisions, optimize treatment outcomes, and ultimately improve the overall quality and efficiency of healthcare delivery. Saving lives, like Rose, with data-driven approaches and personalized care.

* This is an illustrative case and not based on an actual patient, though it is representative of many individuals like her.

Contact us!

If you would like to discuss your work in the healthcare space and learn more about HDAI, please reach out to [email protected]. We would love to speak with you. 

Facebook
Twitter
LinkedIn

Your privacy matters

We believe that an individual’s meaningful control over their own data is as valuable as the data itself. That’s why we are committed to protecting privacy at every turn.
We always:
  • Provide transparency about the information we collect and why we collect it
  • Comply with all applicable privacy rules and regulations
  • Delete personal data from our servers if an individual opts out
We never:
  • Sell data to third parties
  • Share data with third parties besides the primary, explicitly authorized institution
  • Collect data besides what is disclosed
  • Keep personal data for individuals who have opted out

We speak legalese only when we have to, but we do our best to keep it human. Provided below are the full versions of our Privacy Policy and Terms of Service. If you have any questions, don’t hesitate to contact us for clarification.

George Pace

VP Business Development, Payer Markets

George has over two decades of consulting, business development and client success experience in health care, working with both providers and payers to address their most pressing challenges. The bulk of his healthcare career was with The Advisory Board, Optum, Premier and Verisk Health, with a focus on risk mitigation, value-based care and population health management. He is deeply passionate about helping healthcare organizations do their best for their patients and beneficiaries. 

When he’s not working, you will find him playing guitar, riding his bike or spending time with family, friends, and his dog Luna.  

Summer Kramer
VP Clinical Programs

Summer is a clinical pharmacist with over 15 years of experience in the healthcare industry, including hospitals, payors, and start-ups. Summer has focused her career on clinical program development and healthcare analytics with a constant drive to improve patient outcomes.

Residing in the pacific northwest, Summer enjoys hiking, camping, sailing, and traveling. She received her PharmD from the University of New Mexico, College of Pharmacy.  

Karan (Kay) Mansukhani
VP Business Development

Kay has a decade of experience in population health analytics.  Starting his career in Maryland’s state-designated HIE – CRISP,  he was entrusted to set up the infrastructure and data elements needed by health system to achieve CMMIs Triple Aim. Kay is a trained epidemiologist who has a passion for preventive medicine, psychology, and anthropology. Kay enjoys spending lazy days with his wife Sonal, and son Avtar on the beach.  Kay also enjoys listening to podcasts, playing the guitar and badminton. He received his joint MPH MBA from Johns Hopkins University.

Kevin Sampson
VP Finance

Kevin is a CPA with 25 years of executive and managerial experience in accounting, corporate finance, and operations in a variety of industries including medical device, biotechnology, and pharmaceuticals.

By listening and connecting with people, Kevin understands that accurate timely information is vital for everyone in the healthcare system. He received a BS in Accounting and an MBA in Finance and Entrepreneurial Studies from Babson College.

Paul Manberg
VP Clinical and Regulatory Affairs

Paul is an innovative, pragmatic leader with over 40 years’ experience in the medical device and pharmaceutical industries. He has directed clinical trial programs and regulatory activities supporting the successful market introduction of numerous impactful products. He spends his leisure time on the Outer Banks of North Carolina, body surfing and fishing. He received a PhD in pharmacology from The University of North Carolina School of Medicine.

Scott Greenwald
Chief Scientist

With over 25 years’ experience in healthcare research and innovation, Scott is an unprecedented leader in his field, focusing on improved care for everyone. He is an author of over 10 US Patents and over 100 peer-reviewed abstracts and manuscripts. While he’s not immersed in research, you’ll find him playing a mean round of mini golf. He received a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (HST).

Josh Gray VP Analytic Services

Josh has 30 years’ experience in healthcare, including The Advisory Board Company, athenahealth, and Boston Consulting Group. Across his career, he has used a wide range of conventional and unconventional data sources to understand and teach the keys to top performance among the nation’s most innovative health systems and physician groups. Josh enjoys music, hiking, traveling, and watching his daughter take part in synchronized skating competitions. He received an MBA from The Wharton School at the University of Pennsylvania and an undergraduate degree from Brown University.

Carola Endicott
VP Customer Engagement, Marketing

Carola has 30 years’ experience in healthcare, including HMOs, hospitals, and start-ups. Her knowledge and optimistic outlook in operations and leadership, and her passion for making healthcare workers’ lives easier is what drives her devotion to customer engagement. She received an EdM from Harvard University Graduate School of Education.

David Clain Chief Product Officer

David has vast experience with healthcare customers from his time at The Advisory Board Company and athenahealth. His expertise and passion for statistics, strategy, and innovative analytic insights is unrivaled, as is his devotion to the Duke Blue Devils. Looking for that “aha moment” of positive change is what drives him. He received a BA from Duke University.

Margie Ahearn
VP HR

Margie has 25 years of experience in HR leadership. An avid boater, Margie has received numerous awards for excellence in HR and is always looking for challenges to grow professionally and personally. She graduated with an MBA from Southern New Hampshire University.

Nassib Chamoun
Founder and CEO

Nassib is a data scientist, lover of logistical regression and a serial entrepreneur. Previously, he was Founder and CEO of Aspect Medical Systems, a Nasdaq traded company now owned by Medtronic. Outside of work, he enjoys hosting and honing his cooking skills – specializing in Middle Eastern and outdoor feasts. He received an MS from Boston University.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.

What guides our culture

1

We are driven to make a profound impact on US healthcare

2

We operate in the best interests of patients and those who serve them

3

We understand and protect patient privacy and health information security

4

We use data science to enhance, but never replace clinical expertise and judgment

5

We are committed to continuous learning and improvement

6

We bring rigor, discipline, and reliability to our work

7

We start with kindness, assuming good intent in others

8

We are committed to building a diverse, inclusive team where all employees feel welcomed and appreciated

9

We are committed to the well-being of our employees and their families

Our vision

We envision a healthcare system where decisions are routinely informed by personalized care profiles and predictive analytics, which will improve the health of individuals and populations.

Our mission

Deploy a versatile analytic platform that creates a shared understanding of quantified health risks to inform actions with the greatest potential to benefit patients.

Who we are

We collaborate with leading health systems and integrated delivery networks, value-based care and accountable care organizations, physician groups, and commercial payers to improve care delivery and population health while reducing costs and making efficient use of scarce clinical resources.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.